game

analysis

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA hay .m u can play all the games u want

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

Zimhi, loved by the professionals on the ground, game changer in the saving lifes cause, mainly fentanyl overdoses.

$SAVA more games that’s okay I can wait 💪🏼💪🏼

My prediction:
Phase 2 Unbelievable results
FDA fast track
Phase 3 - go ahead
Patients receive sava 
Market cap 40 B by 2024 
Rising to 200 Billion by 2026
Game changer - the only drug in the world to help patients

catalysts are nearing play all the game you want.

Suffice to say, it would be GAME CHANGER. .

$SAVA Sitting here with the Sunday games running and thinking how pleased I will be when the commercial plays showing lives being touched with the chance for many more quality days ahead because of Simufilam.

$SAVA 
Lost in all the analysis are some simple facts;

The drug is safe.

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Salarius Pharmaceuticals Inc

scam

Won’t be buying any more of this garbage.

$SLRX 
This company is the biggest SCAM I’ve ever seen in my whole entire life 
Arthur should do some jail time for misleading investors 
No matter at what price you enter one thing is for sure 
You become a BAGHOLDER

$SLRX morning reminder: stay away from this scam

$SLRX Another perfectly executed bio scam.

loss

!not sure how they can ever come back from
The loss of the patient.

joke

Market is trash and has been since Biden took over.

pump-and-dump

$SLRX how things occur every pump comes a dump!

shit

$SLRX we need to email the shit out of them asking for fda updates on the restart this is some bs

$SLRX This shit gets lower every time I look at it 🙈 … Frustrating

bull

$SLRX glad bulls are banking.. love seeing this

$SLRX She printed for us bulls.. great job

volume

Should hit 0,5$+ once 7AM volume comes in ;) 
 
Looks like could be the next big bio runner !

$HSDT holding well today with low volume!

$HTGM - volume picking up fast! Not surprised to see $10+ today (or higher, based on chart!)

$SLRX took profits on the volume on open and then got stopped out

Great win here wow!

$SLRX big buys incoming hold strong 10+ today with this volume 🔥

hold

$SLRX will see over 10 today buy and hold 🔥

$SLRX come on hold her and she will give u lot more.

$SLRX still holding and will
Continue to hold overnight

International Game Technology PLC

$IGT GAme Tech - Very strong chart, 5 buy signals.

$IGT NEW ARTICLE : International Game Technology is Well Worth the Gamble https://www.stck.pro/news/IGT/37663054

International Game Technology is Well Worth the Gamble $IGT #IGT https://www.marketbeat.com/n/5470926/

International Game Technology upgraded by StockNews.com to strong-buy.

International Game Technology upgraded by StockNews.com to buy.

We have innovated with our existing games and developed new games in virtually every category. As evidenced from our strong Q2 results, including shipping more units than any other  (.  )

technology

IGT received a higher-than average score compared to other information technology and software development companies.

Top Stocks matching your search for "game analysis"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 14, 2023

Jan, 11, 2023

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

IGT

International Game Technology PLC

-4.75%

$27.13 - $25.84

Nov, 20, 2022

Nov, 17, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 14, 2023

Jan, 11, 2023

Jan, 6, 2023

Dec, 30, 2022

Dec, 27, 2022

Dec, 23, 2022

Nov, 7, 2022

Oct, 20, 2022

Oct, 17, 2022

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

IGT

International Game Technology PLC

-4.75%

$27.13 - $25.84